RXRX Recursion Pharmaceuticals, Inc.
Healthcare$2.94+0.00%OpenMarket Cap: $1.31B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
5
Dispositions
10
Buy/Sell Ratio
0.50
Net Shares
-239,858
Shares Acquired
148,170
Shares Disposed
388,028
Total Bought ($)
$0.00
Total Sold ($)
$5.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 19 | Taylor Ben R | officer: Chief Financial Officer | Sell | 25,018 | $3.04 | 1,107,272 |
| Tue May 19 | Khan Najat | director, officer: CEO and President | Sell | 62,701 | $3.04 | 2,199,384 |
| Tue May 19 | Hallett David | officer: Chief Scientific Officer | Sell | 26,657 | $3.04 | 1,070,494 |
| Tue May 19 | Gibson Christopher | director | Sell | 22,821 | $3.04 | 883,735 |
| Fri May 08 | Gibson Christopher | director | Sell | 40,000 | $3.37 | 926,556 |
| Fri May 08 | Gibson Christopher | director | Sell | 20,000 | $0.00 | 906,556 |
| Fri May 08 | Gibson Christopher | director | Sell | 60,000 | $0.00 | 4,343,334 |
| Thu May 07 | Borgeson Blake | director | Sell | 30,000 | $3.52 | 6,199,863 |
| Fri Apr 24 | Gibson Christopher | director | Sell | 40,000 | $3.61 | 906,556 |
| Fri Apr 24 | Gibson Christopher | director | Sell | 40,000 | $0.00 | 4,403,334 |
| Wed Apr 08 | Taylor Ben R | officer: Chief Financial Officer | Sell | 48,028 | $3.11 | 1,132,290 |
| Wed Apr 08 | Gibson Christopher | director | Sell | 40,000 | $3.10 | 906,556 |
| Wed Apr 08 | Gibson Christopher | director | Sell | 40,000 | $0.00 | 4,443,334 |
| Wed Apr 08 | Borgeson Blake | director | Sell | 30,000 | $3.10 | 6,229,863 |
| Thu Apr 02 | Li Dean Y | director | Sell | 3,268 | $0.00 | 1,244,177 |